Last reviewed · How we verify
NCT06619340
EXPAREL IPSA Block in Knee Arthroplasty
Phase 4 trial testing Exparel in Pain, Postoperative in 10 participants. Enrolling by invitation.
20 May 2025
Quick facts
| Lead sponsor | Campbell Clinic |
|---|---|
| Phase | Phase 4 |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 20 May 2024 |
| Primary completion | 20 May 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Exparel — full drug profile →
Conditions studied
- Pain, Postoperative — all drugs for Pain, Postoperative →
- Osteo Arthritis Knee — all drugs for Osteo Arthritis Knee →
Sponsor
Campbell Clinic
Who can join
18 and older, any sex, with Pain, Postoperative or Osteo Arthritis Knee. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a case series to assess the clinical utility of an Intra-articular Posteromedial Surgeon Administered (IPSA) Block in patients undergoing primary unilateral total knee arthroplasty.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06619340
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Exparel
Trials testing the same drug.
- NCT06349772 — Zynrelef vs Exparel: The Battle of Postoperative Pain Control After Robotic Sleeve Gastrectomy · EARLY_PHASE1 · recruiting
- NCT06574022 — Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks · Phase 4 · recruiting
- NCT06350981 — Analgesic Requirement for Post-Operative Pain Control in TLIP Interbody Fusion · Phase 2, PHASE3 · enrolling by invitation
- NCT06274008 — Exparel vs. ACB With Bupivacaine for ACL Reconstruction · Phase 1 · unknown
- NCT05494645 — Exparel Use in Peripheral Nerve Blocks and Local Infiltration for Foot and Ankle Surgery: A Randomized Controlled Trial · Phase 4 · unknown
Other recruiting trials for Pain, Postoperative
Currently open trials in the same condition.
- NCT07512141 — Single Versus Double Drains in the Axillary and Pectoral Regions After Modified Radical Mastectomy · NA · recruiting
- NCT07354581 — Erector Spinae Plane Block vs Quadro-Iliac Plane Block After Lumbar Instrumentation Surgery · NA · recruiting
- NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
- NCT06740214 — Analgesic Efficacy of Different Liposomal Bupivacaine Doses in the Adductor Canal Block for Total Knee Arthroplasty · Phase 3 · recruiting
- NCT07057557 — Aloe Vera vs Paraffin Tulle Dressings for Pain Management in Split Thickness Skin Graft Donor Sites · NA · recruiting
Other Campbell Clinic trials
Trials by the same sponsor.
- NCT07115056 — Extended Oral Tranexamic Acid After Anterior Cruciate Ligament Reconstruction · Phase 4 · withdrawn
- NCT05789784 — Study of Zimmer Biomet Mymobility Application on Reverse Total Shoulder Arthroplasty (RTSA) Outcomes · NA · enrolling by invitation
- NCT05215236 — Opiate Sparing Protocol Randomized Controlled Trial in Open Distal Radius Fracture Repair · NA · completed
- NCT05099276 — Extended Postoperative Oral Tranexamic Acid in Knee Replacement · Phase 4 · unknown
- NCT04575688 — Periarticular Injection Versus Popliteal Block · Phase 4 · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06619340 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Campbell Clinic
- Last refreshed: 1 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06619340.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing